# Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)

Madrigal Pharmaceuticals' stock sees a slight decline due to profit-taking, despite positive clinical trial results and acquisition rumors. The company is also exploring RNAi drugs from China to bolster its MASH pipeline.

### About Madrigal Pharmaceuticals, Inc. Common Stock
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a biopharmaceutical company focused on therapeutics for non-alcoholic steatohepatitis (NASH).  
Madrigal Pharmaceuticals, Inc. Common Stock uses the ticker $MDGL for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) social dominance is up 331.54% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Galaxy Score™ is up 65.38% from the previous week.
- Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) engagements is up 42.75% from the previous week.

### Price: $464.70
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/close.tsv)  
The stock price has experienced a slight decline, attributed to profit-taking following a recent surge fueled by acquisition rumors and positive clinical trial results. Analyst target raises have not been sufficient to offset the selling pressure.  

24-Hour: -3.82%
7-Day: -2.26%
30-Day: -7.37%

1-Year High: $602.80 on 2025-12-22  
1-Year Low: $267.30 on 2025-05-24  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/alt_rank.tsv)  
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently AltRank #690 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +114  
[--] Month: [---] +306  
[--] Months: [---] +828  
[--] Year: [---] +29  
1-Year High: [-----] on 2025-04-19  
1-Year Low: [--] on 2025-05-03  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +17  
[--] Month: [--] +8  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-11-04  
1-Year Low: [--] on 2026-02-05  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] +43%  
[--] Month: [-------] -56%  
[--] Months: [---------] -25%  
[--] Year: [---------] +4.20%  
1-Year High: [-------] on 2025-08-18  
1-Year Low: [-----] on 2026-02-08  

Engagements by network (24h):
Reddit: [--]
News: [--]
X: [-----]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] -34%  
[--] Month: [---] -6.20%  
[--] Months: [-----] -35%  
[--] Year: [------] +35%  
1-Year High: [-----] on 2025-07-17  
1-Year Low: [--] on 2025-12-07  

Mentions by network (24h):
Reddit: [--]
News: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) in the last [--] hours which is up 15% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -45%  
[--] Month: [---] +5.40%  
[--] Months: [-----] -47%  
[--] Year: [-----] +66%  
1-Year High: [---] on 2025-07-17  
1-Year Low: [--] on 2026-02-12  

The most influential creators that mention Madrigal Pharmaceuticals, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@RyshabTalks](/creator/twitter/RyshabTalks)         | [--]    | [-----]     | [--]     | [-----]       |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC)           | [--]    | [-----]     | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [--]          |
| [@WallStSai](/creator/twitter/WallStSai)             | [--]    | [-----]     | [--]     | [--]          |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [--]          |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [--]          |
| [@ChirpSavvy](/creator/twitter/ChirpSavvy)           | [--]    | [---]       | [--]     | [--]          |
| [@ValueForAll1](/creator/twitter/ValueForAll1)       | [--]    | [---]       | [--]     | [--]          |
| [@seedytx19](/creator/twitter/seedytx19)             | [--]    | [-----]     | [--]     | [--]          |
| [@Quantumup1](/creator/twitter/Quantumup1)           | [--]   | [-----]     | [--]     | [--]          |

[View More](/list/creators/$mdgl/100)
  
  
### Sentiment: 77%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/sentiment.tsv)  
Current Value: 77%  
Daily Average: 79%  
[--] Week: 80% -20%  
[--] Month: 68% -13%  
[--] Months: 68% -24%  
[--] Year: 68% -1%  
1-Year High: 98% on 2025-07-17  
1-Year Low: 38% on 2025-12-06  

Most Supportive Themes:
- Acquisition Target: (45%) Madrigal Pharmaceuticals is viewed as a potential acquisition by larger pharmaceutical companies.
- Positive Clinical Trial Results: (30%) Recent positive trial results for Rezdiffra and Madrigal's market leadership in MASH are highlighted.
- Undervalued Stock: (20%) Many investors believe MDGL is undervalued, presenting a strong buying opportunity.
  
Most Critical Themes:
- Profit-Taking and Market Manipulation: (5%) The recent price decline is attributed to profit-taking and potential market manipulation.
  
  
  
### Social Dominance: 0.00552%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/social_dominance.tsv)  
Current Value: 0.00552%  
Daily Average: 0.026%  
[--] Week: 0.00561% +0.00431%  
[--] Month: 0.0063% -0.0063%  
[--] Months: 0.0063% -0.048%  
[--] Year: 0.0063% -0.024%  
1-Year High: 0.145% on 2025-07-17  
1-Year Low: 0.0046% on 2026-02-12  
  
  
### Market Dominance: 0.012%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/market_dominance.tsv)  
Current Value: 0.012%  
Daily Average: 0%  
1-Year High: 0.265% on 2025-03-25  
1-Year Low: 0.00827% on 2025-06-25  
  
  
### Market Cap: $10,554,223,988
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mdgl/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mdgl/time-series/market_cap.tsv)  
Current Value: $10,554,223,988  
Daily Average: $9,008,064,957  
[--] Week: $10,349,366,980 -4.60%  
[--] Month: $10,554,223,988 -6.30%  
[--] Months: $10,554,223,988 +21%  
[--] Year: $10,554,223,988 +44%  
1-Year High: $13,691,125,319 on 2025-12-22  
1-Year Low: $5,940,710,132 on 2025-05-23  

### Top Madrigal Pharmaceuticals, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Some implied moves for earnings next week - [---] companies reporting(2of2): $OLED 8.7% $COCO 11.7% $SEDG 15.6% $MDT 4.9% $BKNG 7.1% $CAR 10.0% $SO 3.3% $ETSY 11.9% $INSM 9.9% $MDGL 8.9% $TZOO 14.9% $FLR 10.1% $TOL 6.0% $MKSI 9.3% $FVRR 11.7% $BLCO 7.5% $PODD 9.0% $WING 13.1% $GPN 9.2% $OXY 4.5% $NTR 4.9% $CAKE 7.2% $CF 4.7% $HLF 14.6% $TAP 6.4% $BHC 5.0% https://www.optionmillionaires.com/some-implied-moves-for-earnings-next-wee-feb-17th-feb-20th-375-companies-reporting/ https://www.optionmillionaires.com/some-implied-moves-for-earnings-next-wee-feb-17th-feb-20th-375-companies-reporting/"  
[X Link](https://x.com/OMillionaires/status/2022684416829440125) [@OMillionaires](/creator/x/OMillionaires) 2026-02-14T14:48Z 143.2K followers, [----] engagements


"My Methodology Quant Scores - as of Feb [--] [----] Set [--] - Potential Investable World Growth 40% IV [--] FCF -100% Dilution 100% Set [--] - Doesn't meet one of the above criteria 🟩 All green bars I own Current Holdings: $CRDO $SNDK $MU $APP $ALAK $RDDT $CRWV $MDGL $TARS $DAVE https://twitter.com/i/web/status/2022672455106527296 https://twitter.com/i/web/status/2022672455106527296"  
[X Link](https://x.com/RyshabTalks/status/2022672455106527296) [@RyshabTalks](/creator/x/RyshabTalks) 2026-02-14T14:01Z [----] followers, [----] engagements


"Portfolio Update as of Feb [--] [----] ================================== 🔴 YTD Returns: -25% 🔴 $SPY -1% 🔴 $QQQ -3% 🟢 $IWM +6% $CRDO 21% $ALAB 18% $CRWV 15% $RDDT 14% $APP 12% $MDGL 12% $DAVE 11% $TARS 9% $SNDK 6% $MU 6% Portfolio is 124% long and has [--] positions. Changes this week: ================================== Bought: $MU $SNDK (3rd on Quant Index I am late to this party but with the insane demand for AI I decided to enter the memory play. Numbers look eye popping I expect this to continue another 12-18 months or so let's see) $APP (Assignment from sell put position. Pretty beat down"  
[X Link](https://x.com/RyshabTalks/status/2022457146818822598) [@RyshabTalks](/creator/x/RyshabTalks) 2026-02-13T23:45Z [----] followers, [----] engagements


"@Pharmdca I really hope Brian can start providing some color on MASH program also. Just looking at $MDGL I think they truly have an exceptional pipeline with late stage clinical data across most programs. I am still a bit on the fence about their amylin asset in light of $NVO's resutls"  
[X Link](https://x.com/Cricket99238/status/2022450736098169092) [@Cricket99238](/creator/x/Cricket99238) 2026-02-13T23:20Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing